Kiryat Bialik, Israel

Adi Abileah

This inventor holds 1 USPTO granted patent. Top assignee: Elscint Ltd.. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adi Abileah: Innovator in Gamma Camera Technology

Introduction

Adi Abileah is a notable inventor based in Kiryat Bialik, Israel. She has made significant contributions to the field of medical imaging, particularly through her innovative work on gamma cameras. Her dedication to enhancing detection efficiency and spatial resolution in imaging technology has positioned her as a key figure in this domain.

Latest Patents

Adi Abileah holds a patent for a gamma camera with a light guide having a greater index of refraction. This invention includes a scintillation crystal with an index of refraction of 1.80-1.90, a collimator for imaging, and an array of photodetectors. The light guide used in her design has an index of refraction of at least 1.60, which is higher than conventional gamma cameras. This advancement has been shown to increase both the sensitivity and spatial resolution of the gamma camera, thereby improving its overall performance.

Career Highlights

Adi Abileah is currently employed at Elscint Ltd., where she continues to develop innovative solutions in medical imaging technology. Her work has not only contributed to her company's success but has also had a lasting impact on the medical field.

Collaborations

Adi has collaborated with several talented individuals, including Giora Gafni and Miguel O Simerman. These partnerships have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.

Conclusion

Adi Abileah's contributions to gamma camera technology exemplify her commitment to advancing medical imaging. Her innovative patent and collaborative efforts highlight her role as a significant inventor in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…